Table 2.
Clinicopathological characteristics of liver specimen donors patients.
| Patients | Case | Age | Gender | Hight (m) | Weight (kg) | BMI (kg/m2) | Tumor characteristics | Non-cancerous liver tissues | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Differentiation | Size | St/Mt | F stage | NAS | Steatosis | Lobular inflammation | Hepatocyte ballooning | |||||||
| NAFLD-HCC | 1 | 65 | M | 1.66 | 86.3 | 31.2 | Mod | 5.2 | Mt | 2 | 1 | 1 | 0 | 0 |
| 2 | 63 | M | 1.62 | 72.6 | 27.6 | Mod | 3 | St | 4 | 1 | 1 | 0 | 0 | |
| 3 | 75 | F | 1.49 | 47.1 | 21.1 | Mod | 4 | St | 3 | 1 | 0 | 1 | 0 | |
| 4 | 67 | M | 1.68 | 70.2 | 24.8 | Mod | 2 | St | 4 | 4 | 1 | 1 | 2 | |
| Liver metastasis | 1 | 59 | F | 1.74 | 60.4 | 19.9 | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A |
| 2 | 47 | F | 1.62 | 56.6 | 21.5 | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | |
| 3 | 56 | M | 1.72 | 78 | 26.4 | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | |
| 4 | 73 | M | 1.71 | 56.3 | 19.3 | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | |
BMI, body mass index; F stage, fibrosis stage; HCC, hepatocellular carcinoma; mod, moderately differentiated; Mt, multiple tumor; NAFLD, non-alcoholic fatty liver disease; NAS, NAFLD activity score; N/A, not available; St, single tumor.